Multi-treatment optimal response-adaptive designs for phase III clinical trials
From MaRDI portal
Publication:744587
Recommendations
- Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint
- Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality
- Optimal response-adaptive designs for continuous responses in phase III trials
- An optimal response-adaptive design with dual constraints
- A new response-adaptive design for continuous treatment responses for phase III clinical trials
Cites work
- scientific article; zbMATH DE number 417962 (Why is no real title available?)
- scientific article; zbMATH DE number 1817583 (Why is no real title available?)
- scientific article; zbMATH DE number 1348603 (Why is no real title available?)
- A birth and death urn for randomized clinical trials: asymptotic methods
- A play-the-winner-type urn design with reduced variability
- A sequential design for maximizing the probability of a favourable response
- Adaptive designs for normal responses with prognostic factors
- An adaptive allocation for continuous response using Wilcoxon-Mann-Whitney score
- Asymptotic inference with response-adaptive treatment allocation designs
- Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials.
- Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses
- Implementing Optimal Allocation in Sequential Binary Response Experiments
- Implementing optimal allocation for sequential continuous responses with multiple treatments
- Inference for a RPW-type clinical trial with repeated monitoring for the treatment of rheumatoid arthritis
- Optimal response-adaptive designs for continuous responses in phase III trials
- Optimal response-adaptive designs for normal responses
- Optimality, Variability, Power
- Response-adaptive designs for continuous outcomes
- Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes
- Sequential Estimation of a Linear Function of Means of Three Normal Populations
- The Randomized Play-the-Winner Rule in Medical Trials
- The generalized Polya's urn design for sequential medical trials
Cited in
(22)- Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress
- Adaptive Designs to Maximize Power in Clinical Trials with Multiple Treatments
- On recent advances in optimal allocation designs in clinical trials
- Benefit–Risk Evaluation of Multi-Stage Adaptive Designs
- Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality
- scientific article; zbMATH DE number 5316748 (Why is no real title available?)
- Optimal response-adaptive designs for continuous responses in phase III trials
- Implementing unequal randomization in clinical trials with heterogeneous treatment costs
- Optimal response-adaptive designs for normal responses
- Multi-arm response-adaptive designs for circular responses
- On Multi-Treatment Adaptive Allocation Design for Dichotomous Response
- Group-sequential response-adaptive designs for multi-armed trials
- Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint
- Multiple-objective response-adaptive repeated measurement designs for clinical trials
- Optimal and ethical designs for hypothesis testing in multi-arm exponential trials
- On optimal designs for clinical trials: an updated review
- Adaptive two‐treatment two‐period crossover design for binary treatment responses
- Making Efficient Use of Patients in Designing Phase III Trials Investigating Simultaneously a Set of Targeted Therapies with Different Targets
- An optimal response-adaptive design for multi-treatment clinical trials with circular responses
- Response-adaptive designs for clinical trials: simultaneous learning from multiple patients
- Sequential monitoring of response-adaptive randomized clinical trials with sample size re-estimation
- Optimal adaptive generalized Pólya urn design for multi-arm clinical trials
This page was built for publication: Multi-treatment optimal response-adaptive designs for phase III clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q744587)
